These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Significance and prevalence of the C282Y gene mutation of primary hemochromatosis in the pathogenesis of pophyria cutanea tarda]. Malina L; Zd'árský E; Dandová S; Michalíková H; Cerná M; Cimburová M Cas Lek Cesk; 2000 Nov; 139(23):728-30. PubMed ID: 11191743 [TBL] [Abstract][Full Text] [Related]
7. [Successful treatment of haemodialysis-related porphyria cutanea tarda with deferoxamine]. Pitche P; Corrin E; Wolkenstein P; Revuz J; Bagot M Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 1):37-9. PubMed ID: 12605155 [TBL] [Abstract][Full Text] [Related]
8. Remission of porphyria cutanea tarda after anastrozole treatment of breast cancer. Bertoli LF; Barton JC Clin Breast Cancer; 2007 Aug; 7(9):716-8. PubMed ID: 17919354 [TBL] [Abstract][Full Text] [Related]
9. A case of porphyria cutanea tarda resulting in digital amputation and improved by anastrazole. Roche M; Daly P; Crowley V; Darby C; Barnes L Clin Exp Dermatol; 2007 May; 32(3):327-8. PubMed ID: 17397360 [No Abstract] [Full Text] [Related]
10. The prevalence of hepatitis C in patients with porphyria cutanea tarda in Stockholm, Sweden. Linde Y; Harper P; Floderus Y; Ros AM Acta Derm Venereol; 2005; 85(2):164-6. PubMed ID: 15823914 [TBL] [Abstract][Full Text] [Related]
11. Porphyria cutanea tarda in a child following multi-agent chemotherapy. LaPresto L; Nyanda H; Knapp CF; Sopkovich J; Nelson CG J Drugs Dermatol; 2014 Apr; 13(4):489-91. PubMed ID: 24719070 [TBL] [Abstract][Full Text] [Related]
12. Severe pruritus after completing pegylated interferon for hepatitis C. Hoffman CJ; Ray SC AIDS Read; 2008 Nov; 18(11):562-5. PubMed ID: 19062400 [TBL] [Abstract][Full Text] [Related]
13. [Porphyria cutanea tarda, hemodialysis and HCV hepatopathy]. Muray S; Casanova JM; Marco MP; Craver L; Martín M; Fernández E Nefrologia; 2002; 22(6):570-3. PubMed ID: 12516291 [TBL] [Abstract][Full Text] [Related]
14. Autoimmunity and HCV infection in porphyria cutanea tarda: a controlled study. Stölzel U; Schuppan D; Tillmann HL; Manns MP; Tannapfel A; Doss MO; Zimmer T; Köstler E Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):43-7. PubMed ID: 11929046 [TBL] [Abstract][Full Text] [Related]
15. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation. Johansen J; Overgaard J; Overgaard M Acta Oncol; 2007; 46(4):525-33. PubMed ID: 17497320 [TBL] [Abstract][Full Text] [Related]
16. Type I (sporadic) porphyria cutanea tarda in a hemodialysis patient: a case report. Tarwater K; Misra S; Misra M Hemodial Int; 2008 Oct; 12 Suppl 2():S38-42. PubMed ID: 18837769 [TBL] [Abstract][Full Text] [Related]
17. Porphyria cutanea tarda affecting a rheumatoid arthritis patient treated with methotrexate: association or coincidence? Chalem P; Ghnassia AM; Nordmann Y; Menkes CJ Rheumatology (Oxford); 1999 May; 38(5):453-6. PubMed ID: 10371285 [TBL] [Abstract][Full Text] [Related]
18. Melatonin formation in pineal gland from rats with hexachlorobenzene experimental porphyria. Llambías EB; Mazzetti MB; Lelli SM; Aldonatti C; San Martín de Viale LC Int J Toxicol; 2007; 26(6):545-51. PubMed ID: 18066970 [TBL] [Abstract][Full Text] [Related]